Relative Bioavailability Study for GSK1838262 (Gabapentin Enacarbil)
NCT00833391
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetics
Healthy Volunteer
Interventions
DRUG:
open label
Sponsor
XenoPort, Inc.